C G Roehrborn Selected Research

alfuzosin (UroXatral)

9/2007	Effects of alfuzosin 10 mg once daily on sexual function in men treated for symptomatic benign prostatic hyperplasia.
1/2007	Rapid onset of action with alfuzosin 10 mg once daily in men with benign prostatic hyperplasia: a randomized, placebo-controlled trial.
8/2003	Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies.
12/2001	Alfuzosin: overview of pharmacokinetics, safety, and efficacy of a clinically uroselective alpha-blocker.
12/2001	Efficacy and safety of once-daily alfuzosin in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a randomized, placebo-controlled trial.
3/2001	Postvoid residual urine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: pooled analysis of eleven controlled studies with alfuzosin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

C G Roehrborn Research Topics

Disease

21	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 11/2015 - 01/2000
18	Lower Urinary Tract Symptoms 11/2015 - 01/2001
4	Urinary Retention 04/2011 - 05/2000
4	Prostatic Neoplasms (Prostate Cancer) 01/2009 - 11/2000
3	Dizziness (Lightheadedness) 09/2007 - 12/2001
1	Urinary Tract Infections (Urinary Tract Infection) 01/2017
1	Infections 01/2017
1	Retrograde Ejaculation 06/2011
1	Overactive Urinary Bladder (Overactive Bladder) 04/2011
1	Neoplasms (Cancer) 01/2009
1	Adenocarcinoma 01/2002
1	Orthostatic Hypotension (Postural Hypotension) 12/2001
1	Cystocele 07/2001
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2000
1	Kidney Calculi (Kidney Stone) 11/2000
1	Ataxia (Dyssynergia) 03/2000
1	Hemorrhage 03/2000

Drug/Important Bio-Agent (IBA)

6	alfuzosin (UroXatral)FDA Link 09/2007 - 03/2001
5	Prostate-Specific Antigen (Semenogelase)IBA 12/2008 - 01/2000
3	Dutasteride (Avodart)FDA Link 01/2009 - 01/2006
3	Finasteride (Propecia)FDA LinkGeneric 08/2001 - 05/2000
2	Tamsulosin (Flomax)FDA LinkGeneric 01/2009 - 01/2009
2	Terazosin (Hytrin)FDA LinkGeneric 11/2001 - 01/2001
1	Formaldehyde (Formol)FDA Link 01/2017
1	Testosterone (Sustanon)FDA Link 11/2015
1	Tadalafil (Cialis)FDA Link 11/2015
1	Estrogens (Estrogen)FDA Link 11/2015
1	erteberelIBA 03/2015
1	Estrogen Receptor betaIBA 03/2015
1	silodosin FDA Link 06/2011
1	Muscarinic AntagonistsIBA 04/2011
1	AntigensIBA 12/2008
1	Dihydrotestosterone (Androstanolone)IBA 01/2006
1	AndrogensIBA 07/2002
1	VA 061 (VA061)IBA 07/2002
1	Doxazosin (Cardura)FDA LinkGeneric 08/2001
1	SuspensionsIBA 07/2001
1	alpha Adrenergic ReceptorsIBA 01/2001
1	SeleniumIBA 11/2000

Therapy/Procedure

7	Therapeutics 01/2009 - 05/2000
1	Prostatectomy (Retropubic Prostatectomy) 01/2002
1	Anesthesia 01/2001
1	Transurethral Resection of Prostate (TURP) 01/2001
1	Diet Therapy (Therapy, Diet) 11/2000
1	Secondary Prevention 11/2000
1	Prostheses and Implants (Prosthesis) 03/2000
1	Radiofrequency Therapy 01/2000
1	Electrodes (Electrode) 01/2000